19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace





powered by centersite dot net
Women's Health
Basic InformationLatest News
When Arteries Narrow, Chest Pain Can Come Earlier for Women Than MenRacial, Ethnic Gaps in Insurance Put Moms, Babies at Risk: StudyStatins Might Reduce Harms From Breast Cancer ChemoExpectant Moms: Take Care and Don't Panic About CoronavirusGene Tests May Guard Older Breast Cancer Patients Against Other TumorsAHA News: Changing the Way We View Women's Heart Attack SymptomsMaria Shriver Sounds the Alarm on Women and Alzheimer'sAHA News: Estrogen Therapy in Early Menopause May Help Keep Arteries ClearDon't Wait, for Your Baby's Sake: Quit Smoking Before You're PregnantFemale Firefighters Face Higher Exposure to CarcinogensNew Moms Need to Watch Out for High Blood PressureBad Sleep, Bad Diet = Bad Heart?A Woman's Guide to Skin Care During and After MenopauseAHA News: What Women Need to Know About Breast Cancer and Heart DiseaseIs High Blood Pressure in First Pregnancy a Harbinger of Heart Trouble?AHA News: Domestic Abuse May Do Long-Term Damage to Women's Health'Couch Potato' Lifestyle Poses Danger to Women's HeartsWomen Patients Still Missing in Heart Research2 in 3 Women Unhappy With Their Breast Size. Could That Harm Their Health?Pregnant Moms Who Smoke, Drink Put Babies at Risk of SIDS: Study2 in 3 Americans Unaware That Heart Disease Is Leading Killer of WomenEmployers Need to Do More to Help Breastfeeding Moms: SurveyStrong Support Network Is Key to Women's Cancer Recovery: StudyCervical Cancer Could All But Disappear in North America by 2040Pregnancy, Breastfeeding May Guard Against Early MenopauseMany Moms-to-Be Are Stressed, and it Might Affect Baby's BrainLess Sex Could Mean Earlier MenopauseWomen's Blood Pressure Rises Earlier, Faster Than Men'sTrauma of Miscarriage May Trigger PTSDA Lifetime of Fitness Helps Women's Muscles in Old AgeLarge Study Shows No Strong Link Between Baby Powder, Ovarian CancerVictoria's Secret Models Are Skinnier Now, as Average Woman's Waistline WidensMany Girls, Young Women Getting Unnecessary Pelvic ExamsAI Beat Humans in Spotting Breast TumorsBreast Density Alerts Might Not Be Helping WomenHealth Tip: Breast Cancer Screening GuidelinesShedding Pounds May Shrink Breast Cancer RiskMost Long-Term Breast Cancer Survivors Die From Other CausesNew Study Shakes Up Thinking on Hormone Replacement TherapyBreast Cancer Drug Shows Long-Lasting Prevention PowerBreastfeeding May Bring Added Bonus for Women With MSAre Superbugs Making Themselves at Home in Your Makeup Bag?Health Tip: Heart Attack Symptoms in WomenIs Childbirth More Dangerous in Rural Areas?Good Workouts Might Extend a Woman's LifeDomestic Abuse Can Leave Legacy of Poor HealthMom-to-Be's Diabetes May Up Odds of Heart Disease in Her KidsStudy Links Hair Straighteners, Dyes to Breast CancerA Birth Control Pill You Take Just Once a Month?Birth Control Pill May Alter Part of Women's Brains
Questions and AnswersVideosLinksBook ReviewsSelf-Help Groups
Related Topics

Wellness and Personal Development
Mental Disorders

Breast Cancer Drug Shows Long-Lasting Prevention Power

HealthDay News
by -- Robert Preidt
Updated: Dec 12th 2019

new article illustration

THURSDAY, Dec. 12, 2019 (HealthDay News) -- Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50% less likely to have been struck by the disease, new research shows.

The trial included more than 3,800 postmenopausal women at high risk for breast cancer. They were deemed to be at high risk for a variety of reasons, including having two or more blood relatives with breast cancer, having a mother or sister who developed breast cancer before age 50, and having a mother or sister who had breast cancer in both breasts.

About half of the participants were randomly selected to take the aromatase inhibitor drug anastrozole (Arimidex) for five years and about half took a placebo.

As one breast cancer expert unconnected to the study explained, drugs like anastrozole are taken to prevent breast cancer's return.

"One of the most important parts of my job as a breast program director is running our 'high risk' clinic, and the most common question that I get from our patients is 'What else can I do to prevent breast cancer?'" said Dr. Alice Police, who directs breast surgery at the Northwell Health Cancer Institute in Sleepy Hollow, N.Y.

"Aside from lifestyle interventions, such as diet and exercise, and prophylactic surgery, there are medications that we know can reduce the future risk of breast cancer in this group by 50% or more," she said. "Tamoxifen is the drug that has historically been used for this purpose and this study looks at the drug anastrozole as an alternative."

The new findings were to be presented Thursday at the annual San Antonio Breast Cancer Symposium, and were published simultaneously in The Lancet.

According to study author Jack Cuzick, the trial "was designed to investigate whether five years of anastrozole can safely and effectively prevent breast cancer in postmenopausal women who are at high risk for the disease."

In 2013, the research team "reported that in the first seven years of follow-up, anastrozole significantly reduced breast cancer incidence compared with placebo, and that it did so with very few side effects," Cuzick noted in a symposium news release.

"Our new data show that after a median of 10.9 years of follow-up, there continues to be a significant reduction in breast cancer incidence," said Cuzick. He is the director of the Wolfson Institute of Preventive Medicine, head of the Centre for Cancer Prevention, and the John Snow Professor of Epidemiology at Queen Mary University of London.

"It is exciting to see that anastrozole has a continued impact on breast cancer incidence even after stopping treatment, as this strengthens the case for its use as a breast cancer prevention therapy," he added.

"Another way to consider the data is that it translates into an estimated 29 women needing to be treated with anastrozole for five years to prevent one breast cancer during treatment and in the next five years," Cuzick explained.

"This is far fewer women than the estimated 49 women that need to be treated with tamoxifen for five years to prevent one breast cancer in the same time period," he said.

Cuzick noted that the preventive benefits of anastrozole are seen for estrogen receptor-positive breast cancer and for ductal carcinoma in situ, but not for estrogen receptor-negative breast cancer. Anastrozole targets the estrogen pathway.

The study received funding from drug maker AstraZeneca and study co-chair Cuzick is a consultant for Myriad Genetics.

Police called the new findings "exciting and important."

"Even after stopping the drug, the protection continued for at least five more years for most types of breast cancer," she noted. "I now have an even better answer for the question 'What else can I do?'"

Dr. Lauren Cassell is chief of breast surgery at Lenox Hill Hospital in New York City. Reading over the findings, she agreed that the data was "extremely exciting news" for patients.

"We have known that tamoxifen can decrease a woman's risk of developing breast cancer, which actually persists longer than the five years that it was taken," Cassell said, but "we did not have the same data for anastrozole."

Cassell added that there are pros and cons for using either tamoxifen or anastrozole.

"Anastrozole does not carry an increased risk for uterine cancer or blood clots, which we find with tamoxifen," she said, "but many patients complain of significant joint pains [with anastrozole], which causes them to discontinue the medication."

So far, it's not clear if anastrozole reduces the risk of breast cancer death, so the researchers plan to continue following the study participants to try to answer that question.

More information

The U.S. National Cancer Institute has more on breast cancer prevention.